FerriScans and Cardiac T2

The procurement process involves Birmingham Women's and Children's NHS Foundation Trust as the buying organisation, with University Hospitals Birmingham NHS Foundation Trust acting as the procuring entity. The contract is titled "FerriScans and Cardiac T2" and falls under the health services category. Located in Birmingham, the contract pertains to the procurement of health service analyses required by Haematology teams.

The procurement stage is in the award phase, having been completed through a direct procurement method without competition, as it falls below the threshold. Significant date details include the contract period, starting on 1st April 2025 and ending on 31st March 2026. The buying organisation has approved an active contract with Resonance Health, signed on 31st March 2025.

This tender presents a business growth opportunity, particularly for small and medium-sized enterprises (SMEs) involved in health services, given that Resonance Health, a VCSE organisation, was awarded this contract. The procurement being conducted without competition could set a precedent for future direct procurements, favouring businesses capable of leveraging niche expertise in health analysis services. Companies with established capabilities in health diagnostics and scanning technologies may find opportunities to align with similar public health contracts across various NHS trusts and departments within the region.